Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: 2-Year Interim Results from the Phase 3 Rising Up Study.
Norito KatohYukihiro OhyaHiroyuki MurotaMasanori IkedaXiaofei HuKimitoshi IkedaJohn LiuTakuya SasakiEliza M RaymundoHenrique D TeixeiraHidehisa SaekiPublished in: Dermatology and therapy (2022)
ClinicalTrials.gov identifier, NCT03661138.
Keyphrases